“Lighten This Burden of Ours”: Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 20
Abstract
Background: Long-acting injectable (LAI) antiretroviral therapy (ART) may offer persons living with HIV (PLWH) an attractive alternative to pill-based treatment options, yet acceptability data remain scant, especially in sub-Saharan Africa. Methods: We conducted 6 focus group discussions with PLWH, including key stake holder groups, and analyzed data with content analysis. Results: Initial reactions to the idea of LAI-ART were often positive. The primary advantages voiced were potential to facilitate improved adherence and alleviate the burden of daily pill-taking while avoiding inadvertent disclosure and HIV stigma. Potential side effects were a particular concern of the women. Most participants preferred clinic-based administration over self-injections at home due to concerns about safety, privacy, and potential need for refrigeration. Conclusions: LAI-ART may be acceptable in Kenya, provided injections are infrequent and delivered in a clinic setting. However, HIV stigma, fear of potential side effects, and limited clinical capacity would need to be addressed.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI027757)
This publication has 22 references indexed in Scilit:
- Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapyAdvanced Drug Delivery Reviews, 2016
- Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.AIDS and Behavior, 2016
- Injectable agents for pre-exposure prophylaxisCurrent Opinion in HIV and AIDS, 2015
- Implementation challenges for long-acting antivirals as treatmentCurrent Opinion in HIV and AIDS, 2015
- Evolution of implantable and insertable drug delivery systemsJournal of Controlled Release, 2014
- Medical Injection Use Among Adults and Adolescents Aged 15 to 64 Years in KenyaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- Long-Acting Parenteral Nanoformulated Antiretroviral Therapy: Interest and Attitudes of HIV-Infected PatientsNanomedicine, 2013
- A situated-Information Motivation Behavioral Skills Model of Care Initiation and Maintenance (sIMB-CIM): An IMB Model Based Approach to Understanding and Intervening in Engagement in Care for Chronic Medical ConditionsJournal of Health Psychology, 2011
- HIV drugs for treatment, and for preventionThe Lancet, 2010
- Three Approaches to Qualitative Content AnalysisQualitative Health Research, 2005